Who Got Funded
Power, Photonics, Energy, Quantum — Six Rounds, Five Countries, One Week
Skeleton Technologies — Tallinn, Estonia · >$100M · Strategic investment · Energy storage / Supercapacitors · Siemens
The exclusive distribution deal for data center markets is the substance. Siemens is staking its AI data center electrical infrastructure lineup on Skeleton's technology — and blocking rivals from the same supply.
Salience Labs — Oxford, UK · $125M · Series B · Photonic networking chips · Bullhound Capital (lead), AMD Ventures, Intel Capital, SBI Group, Hudson River Trading, British Business Bank
Oversubscribed. Salience demonstrated a live 64-port all-optical switch at ECOC 2026 weeks before the close — the round followed proof, not promise. Targeting 128- and 256-port systems next.
Rabot Energy — Hamburg, Germany · €50M · Series B · Virtual Power Plant / EnergyTech · Endeit Capital (lead), DeepTech & Climate Fonds, HV Capital, High-Tech Gründerfonds, Bosch Ventures
€200M ARR, 200,000+ customers. The round targets one million customers and deeper grid service contracts. Already generating revenue from services that grid operators pay for — not from electricity margin alone.
Dougs — Lyon, France · €50M · Growth · AI-powered accounting · Expedition Growth Capital
Bootstrapped for eight years. Now 50,000+ small-business clients and €50M+ ARR. Expedition, an existing investor, is doubling down on Dougs' bet that AI agents can replace the manual bookkeeping layer for France's 4 million sole traders.
Qilimanjaro Quantum Tech — Barcelona, Spain · €19.6M · Series A (first close) · Quantum computing hardware · Indra Group / IndraMind (lead, €10M), SETT (€9.6M)
Eight deployed quantum systems, three at the Barcelona Supercomputing Center. Indra's IndraMind and Spanish state entity SETT make this a sovereign capital play — Spain is building domestic quantum hardware rather than buying American or Chinese systems. A €100–150M round planned for 2027.
Undecimal Bio — Cambridge, UK · $18M (~€16M) · Seed · siRNA drug delivery · 4BIO Capital (co-lead), IQ Capital (co-lead), Verve Ventures, Harel Tech, Entree Capital
Solving the "liver trap" — most RNA medicines accumulate in the liver before reaching target tissues. Its DELiveri platform screens compounds that carry siRNA into specific cells. Oversubscribed at seed with zero prior external capital.
Six rounds across five countries: Estonia, UK (twice), Germany, France, Spain. The three largest all address AI physical infrastructure; the other three show continued depth in fintech automation, quantum hardware, and biotech delivery platforms. The week's capital was not concentrated in one city or one sector.